1 completed, 1 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Hereditary Angioedema Attack: new trials by email Literature Review of Hereditary Angioedema Attack trials Research Report on Hereditary Angioedema Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema Deucrictibant, Placebo - Hereditary Angioedema, Hereditary Angioedema Type I | Phase 3 | Completed | Pharvaris Netherlands B.V. | 134 | 2024-02-26 | 2025-11-21 |
| Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema deucrictibant - Hereditary Angioedema, Hereditary Angioedema Type I | Phase 2 / Phase 3 | Enrolling by invitation | Pharvaris Netherlands B.V. | 150 | 2022-12-28 | 2026-07-21 |
Angioedemas, Hereditary (2) · Hereditary Angioedema Type III (2) · Hereditary Angioedema Types I and II (2)
Angioedema (2) · Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hereditary Complement Deficiency Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Primary Immunodeficiency Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Urticaria (2) · Vascular Diseases (2)
Pharvaris Netherlands B.V. (2)
Argentina (2) · Australia (2) · Austria (2) · Brazil (2) · Bulgaria (2) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Hong Kong (2) · Hungary (2) · Italy (2) · Japan (2) · Netherlands (2) · Poland (2)
2023 (1)